Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
Vise andre og tillknytning
2018 (engelsk)Inngår i: Journal of Pathology, ISSN 0022-3417, E-ISSN 1096-9896, Vol. 246, nr 3, s. 311-322Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Unstable and dysfunctional tumor vasculature promotes cancer progression and spread. Signal transduction by the pro-angiogenic vascular endothelial growth factor (VEGF) receptor-2 (VEGFR2) is modulated by VEGFA-dependent complex formation with neuropilin 1 (NRP1). NRP1 expressed on tumor cells can form VEGFR2/NRP1 trans-complexes between tumor cells and endothelial cells which arrests VEGFR2 on the endothelial surface, thus interfering with productive VEGFR2 signaling. In mouse fibrosarcoma, VEGFR2/NRP1 trans-complexes correlated with reduced tumor vessel branching and reduced tumor cell proliferation. Pancreatic ductal adenocarcinoma (PDAC) strongly expressed NRP1 on both tumor cells and endothelial cells, in contrast to other common cancer forms. Using proximity ligation assay, VEGFR2/NRP1 trans-complexes were identified in human PDAC tumor tissue, and its presence was associated with reduced tumor vessel branching, reduced tumor cell proliferation, and improved patient survival after adjusting for other known survival predictors. We conclude that VEGFR2/NRP1 trans-complex formation is an independent predictor of PDAC patient survival. 

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2018. Vol. 246, nr 3, s. 311-322
Emneord [en]
VEGF, neuropilin 1, pancreatic adenocarcinoma, trans-complex, branching
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-152971DOI: 10.1002/path.5141ISI: 000447161600007PubMedID: 30027561Scopus ID: 2-s2.0-85052864766OAI: oai:DiVA.org:umu-152971DiVA, id: diva2:1260269
Forskningsfinansiär
Swedish Research Council, 2015-02375Swedish Cancer Society, CAN2016/578Knut and Alice Wallenberg Foundation, KAW 2015.0030Knut and Alice Wallenberg Foundation, KAW 2015.0275Tilgjengelig fra: 2018-11-01 Laget: 2018-11-01 Sist oppdatert: 2023-03-24bibliografisk kontrollert

Open Access i DiVA

fulltext(5234 kB)297 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 5234 kBChecksum SHA-512
cd0b33fc97f0e7d22c808f01aa693c12e74ac0099e93cd9e73806fc4c14710bb1da357619b7a15f7a068ea5d31163ae4d6cfccc781913f6c88de5e03ff2a6004
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Franklin, OskarSund, MalinÖhlund, Daniel

Søk i DiVA

Av forfatter/redaktør
Franklin, OskarSund, MalinÖhlund, Daniel
Av organisasjonen
I samme tidsskrift
Journal of Pathology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 297 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 542 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf